Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

Similar articles for PubMed (Select 22607679)

1.

Synthesis and evaluation of [18F]Fluorobutyl ethacrynic amide: a potential PET tracer for studying glutathione transferase.

Huang HL, Yeh CN, Chang KW, Chen JT, Lin KJ, Chiang LW, Jeng KC, Wang WT, Lim KH, Chen CG, Lin KI, Huang YC, Lin WJ, Yen TC, Yu CS.

Bioorg Med Chem Lett. 2012 Jun 15;22(12):3998-4003. doi: 10.1016/j.bmcl.2012.04.091. Epub 2012 Apr 30.

PMID:
22607679
2.

18F-glutathione conjugate as a PET tracer for imaging tumors that overexpress L-PGDS enzyme.

Huang HL, Huang YC, Lee WY, Yeh CN, Lin KJ, Yu CS.

PLoS One. 2014 Aug 11;9(8):e104118. doi: 10.1371/journal.pone.0104118. eCollection 2014.

3.

Investigation of brain tumors using (18)F-fluorobutyl ethacrynic amide and its metabolite with positron emission tomography.

Huang YC, Huang HL, Yeh CN, Lin KJ, Yu CS.

Onco Targets Ther. 2015 Jul 24;8:1877-85. doi: 10.2147/OTT.S78404. eCollection 2015.

4.

Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas.

Moon CM, Bang S, Chung JB, Park SW, Song SY, Yun M, Lee JD.

J Gastroenterol Hepatol. 2008 May;23(5):759-65. Epub 2007 Oct 10.

PMID:
17931372
5.
6.

Synthesis and evaluation of (S)-2-(2-[18F]fluoroethoxy)-4-([3-methyl-1-(2-piperidin-1-yl-phenyl)-butyl-carbamoyl]-methyl)-benzoic acid ([18F]repaglinide): a promising radioligand for quantification of pancreatic beta-cell mass with positron emission tomography (PET).

Wängler B, Schneider S, Thews O, Schirrmacher E, Comagic S, Feilen P, Schwanstecher C, Schwanstecher M, Shiue CY, Alavi A, Höhnemann S, Piel M, Rösch F, Schirrmacher R.

Nucl Med Biol. 2004 Jul;31(5):639-47.

PMID:
15219283
7.

Combined hepatocellular carcinoma and cholangiocarcinoma with high F-18 fluorodeoxyglucose positron emission tomographic uptake.

Shiomi S, Sasaki N, Kawashima D, Jomura H, Fukuda T, Kuroki T, Koyama K, Kawabe J, Ochi H.

Clin Nucl Med. 1999 May;24(5):370-1. No abstract available. Erratum in: Clin Nucl Med 1999 Sep;24(9):715.

PMID:
10232488
8.

The role of (18)F-fluorodeoxyglucose positron emission tomography in the diagnosis, staging, and follow-up of cholangiocarcinoma.

Moon CM, Bang S, Chung JB.

Surg Oncol. 2011 Mar;20(1):e10-7. doi: 10.1016/j.suronc.2009.08.003. Epub 2009 Oct 4. Review.

PMID:
19804967
9.

Animal PET for thioacetamide-induced rat cholangiocarcinoma: a novel and reliable platform.

Yeh CN, Lin KJ, Hsiao IT, Yen TC, Chen TW, Jan YY, Chung YH, Lin CF, Chen MF.

Mol Imaging Biol. 2008 Jul-Aug;10(4):209-16. doi: 10.1007/s11307-008-0141-8. Epub 2008 May 20.

PMID:
18491193
10.

Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma.

Kim YJ, Yun M, Lee WJ, Kim KS, Lee JD.

Eur J Nucl Med Mol Imaging. 2003 Nov;30(11):1467-72. Epub 2003 Aug 7.

PMID:
14579085
11.

18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer.

Corvera CU, Blumgart LH, Akhurst T, DeMatteo RP, D'Angelica M, Fong Y, Jarnagin WR.

J Am Coll Surg. 2008 Jan;206(1):57-65. Epub 2007 Oct 1.

PMID:
18155569
12.

Evaluation of [11C]hemicholinium-15 and [18F]hemicholinium-15 as new potential PET tracers for the high-affinity choline uptake system in the heart.

Gao M, Miller MA, DeGrado TR, Mock BH, Lopshire JC, Rosenberger JG, Dusa C, Das MK, Groh WJ, Zipes DP, Hutchins GD, Zheng QH.

Bioorg Med Chem. 2007 Feb 1;15(3):1289-97. Epub 2006 Nov 10.

PMID:
17116396
13.

Synthesis and preliminary evaluation of 18F-labeled pyridaben analogues for myocardial perfusion imaging with PET.

Mou T, Zhao Z, Fang W, Peng C, Guo F, Liu B, Ma Y, Zhang X.

J Nucl Med. 2012 Mar;53(3):472-9. doi: 10.2967/jnumed.111.088096. Epub 2012 Feb 2.

14.

Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging.

Kim JY, Kim MH, Lee TY, Hwang CY, Kim JS, Yun SC, Lee SS, Seo DW, Lee SK.

Am J Gastroenterol. 2008 May;103(5):1145-51. doi: 10.1111/j.1572-0241.2007.01710.x. Epub 2008 Jan 2.

PMID:
18177454
15.

1-[3-(2-[18F]fluoropyridin-3-yloxy)propyl]pyrrole-2,5-dione: design, synthesis, and radiosynthesis of a new [18F]fluoropyridine-based maleimide reagent for the labeling of peptides and proteins.

de Bruin B, Kuhnast B, Hinnen F, Yaouancq L, Amessou M, Johannes L, Samson A, Boisgard R, Tavitian B, Dollé F.

Bioconjug Chem. 2005 Mar-Apr;16(2):406-20.

PMID:
15769096
16.

Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.

Ross TL, Honer M, Lam PY, Mindt TL, Groehn V, Schibli R, Schubiger PA, Ametamey SM.

Bioconjug Chem. 2008 Dec;19(12):2462-70. doi: 10.1021/bc800356r.

PMID:
19053298
17.

Different glucose uptake and glycolytic mechanisms between hepatocellular carcinoma and intrahepatic mass-forming cholangiocarcinoma with increased (18)F-FDG uptake.

Lee JD, Yang WI, Park YN, Kim KS, Choi JS, Yun M, Ko D, Kim TS, Cho AE, Kim HM, Han KH, Im SS, Ahn YH, Choi CW, Park JH.

J Nucl Med. 2005 Oct;46(10):1753-9.

18.

Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer.

Kluge R, Schmidt F, Caca K, Barthel H, Hesse S, Georgi P, Seese A, Huster D, Berr F.

Hepatology. 2001 May;33(5):1029-35.

PMID:
11343227
19.

Radiolabeling and in vitro and in vivo evaluation of [18F]-FE-DABP688 as a PET radioligand for the metabotropic glutamate receptor subtype 5.

Honer M, Stoffel A, Kessler LJ, Schubiger PA, Ametamey SM.

Nucl Med Biol. 2007 Nov;34(8):973-80. Epub 2007 Sep 19.

PMID:
17998101
20.

Fluorine-18 labeled galactosyl-neoglycoalbumin for imaging the hepatic asialoglycoprotein receptor.

Yang W, Mou T, Peng C, Wu Z, Zhang X, Li F, Ma Y.

Bioorg Med Chem. 2009 Nov 1;17(21):7510-6. doi: 10.1016/j.bmc.2009.09.017. Epub 2009 Sep 15.

PMID:
19796957
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk